137 related articles for article (PubMed ID: 32095481)
1. Pharmacokinetic comparison between fixed-dose combination of fimasartan/amlodipine 60/10 mg and the corresponding loose combination through partial replicated crossover study in healthy subjects.
Yang E; Lee S; Lee H; Hwang I; Jang IJ; Yu KS; Lee S
Transl Clin Pharmacol; 2019 Dec; 27(4):134-140. PubMed ID: 32095481
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic comparison between a fixed-dose combination of fimasartan/amlodipine/hydrochlorothiazide 60/10/25 mg and a corresponding loose combination of fimasartan/amlodipine 60/25 mg and hydrochlorothiazide 25 mg in healthy subjects.
Jung J; Lee S; Oh J; Lee S; Jang IJ; Lee D; Yu KS
Transl Clin Pharmacol; 2021 Mar; 29(1):53-64. PubMed ID: 33855001
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic comparison of a fixed-dose combination versus concomitant administration of fimasartan, amlodipine, and rosuvastatin using partial replicated design in healthy adult subjects.
Oh M; Ghim JL; Park SE; Kim EY; Shin JG
Drug Des Devel Ther; 2018; 12():1157-1164. PubMed ID: 29780236
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the Pharmacokinetics of Highly Variable Drugs in Healthy Subjects Using a Partial Replicated Crossover Study: A Fixed-Dose Combination of Fimasartan 120 mg and Atorvastatin 40 mg versus Separate Tablets.
Hwang JG; Yu KS; Lee S
Drug Des Devel Ther; 2020; 14():1953-1961. PubMed ID: 32546962
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic Comparison of a Fixed-Dose Combination of Candesartan Cilexetil/Amlodipine/Atorvastatin Versus Co-administration of Individual Formulations in Healthy Participants.
Kim JH; Song JH; Kim M; Hong JH; Sunwoo J; Jung JG
Adv Ther; 2024 Jul; 41(7):2808-2825. PubMed ID: 38771476
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Pharmacokinetics of a Fixed-Dose Combination of Amlodipine/Losartan/Rosuvastatin with Concomitant Administration of Amlodipine/Losartan and Rosuvastatin in Healthy Volunteers.
Yoon DY; Park SI; Jung JA; Kim YI; Jang IJ; Chung JY
Drug Des Devel Ther; 2020; 14():661-668. PubMed ID: 32109991
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic and bioequivalence study comparing a fimasartan/rosuvastatin fixed-dose combination with the concomitant administration of fimasartan and rosuvastatin in healthy subjects.
Kang WY; Seong SJ; Ohk B; Gwon MR; Kim BK; Cho S; Shim WS; Lee KT; Kim EH; Yang DH; Lee HW; Yoon YR
Drug Des Devel Ther; 2018; 12():3607-3615. PubMed ID: 30464392
[TBL] [Abstract][Full Text] [Related]
8. Investigation of bioequivalence of a new fixed-dose combination of acarbose and metformin with the corresponding loose combination as well as the drug-drug interaction potential between both drugs in healthy adult male subjects.
Kim S; Jang IJ; Shin D; Shin DS; Yoon S; Lim KS; Yu KS; Li J; Zhang H; Liu Y; Brendel E; Blode H; Wang Y
J Clin Pharm Ther; 2014 Aug; 39(4):424-31. PubMed ID: 24806030
[TBL] [Abstract][Full Text] [Related]
9. Comparisons of the pharmacokinetics and tolerability of fixed-dose combinations of amlodipine besylate/losartan and amlodipine camsylate/losartan in healthy subjects: a randomized, open-label, single-dose, two-period, two-sequence crossover study.
Choi Y; Lee S; Cho SM; Kang WH; Nam KY; Jang IJ; Yu KS
Drug Des Devel Ther; 2016; 10():3021-3028. PubMed ID: 27703330
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic and Safety Profiles of a Fixed-Dose Combination of Amlodipine, Valsartan, and Atorvastatin: A 3-Period Replicate Crossover Study.
Kim S; Ko JW; Kim JR
Clin Pharmacol Drug Dev; 2020 Apr; 9(3):386-394. PubMed ID: 31373174
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and bioequivalence of fixed-dose combination of candesartan cilexetil/amlodipine besylate (16/10 mg) versus coadministration of individual formulations in healthy subjects.
Lee HW; Kang WY; Jung W; Gwon MR; Yang DH; Kim EH; Cho K; Yoon YR; Seong SJ
Transl Clin Pharmacol; 2020 Jun; 28(2):92-101. PubMed ID: 32656160
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic Comparison Between a Fixed-Dose Combination of Atorvastatin/Omega-3-Acid Ethyl Esters and the Corresponding Loose Combination in Healthy Korean Male Subjects.
Khwarg J; Lee S; Jang IJ; Kang WH; Lee HJ; Kim KY; Jeong KS; Won C; Choi YW; Ha DC; Jung R; Han MG; Jung WT; Nam KY; Kim Y; Yu KS; Oh J
Drug Des Devel Ther; 2024; 18():395-406. PubMed ID: 38352172
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic and bioequivalence study of a telmisartan/S-amlodipine fixed-dose combination (CKD-828) formulation and coadministered telmisartan and S-amlodipine in healthy subjects.
Kang WY; Seong SJ; Ohk B; Gwon MR; Kim BK; La S; Kim HJ; Cho S; Yoon YR; Yang DH; Lee HW
Drug Des Devel Ther; 2018; 12():545-553. PubMed ID: 29559771
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of a Fixed-Dose Combination of Amlodipine/Losartan and Chlorthalidone Compared to Concurrent Administration of the Separate Components.
Jeon I; Moon SJ; Park SI; Choi Y; Jung J; Yu KS; Chung JY
Clin Pharmacol Drug Dev; 2022 Jan; 11(1):91-99. PubMed ID: 34159751
[TBL] [Abstract][Full Text] [Related]
15. Bioequivalence Study of a New Fixed-dose Combination Tablet Containing S-Amlodipine Nicotinate and Olmesartan Medoxomil in Healthy Korean Male Subjects.
Oh MJ; Hwang HH; Kim HG; Lee GH; Cho YS; Lee SY; Kang SY; Cho KH; Lee YY; Lee YJ; Jang CG; Lee SY
Clin Ther; 2017 Jul; 39(7):1371-1379. PubMed ID: 28625505
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic Equivalence of the High Dose Strength Fixed-Dose Combination Tablet of Gemigliptin/Metformin Sustained Release (SR) and Individual Component Gemigliptin and Metformin XR Tablets in Healthy Subjects.
Cho YS; Lee SH; Lim HS; Bae KS
J Korean Med Sci; 2018 Oct; 33(41):e258. PubMed ID: 30288156
[TBL] [Abstract][Full Text] [Related]
17. A Fixed-Dose Combination Of Gemigliptin And Rosuvastatin Exhibits Similar Pharmacokinetics, Pharmacodynamics, And Safety Compared To That Of A Loose Combination In Healthy Subjects.
Kim E; Park KR; Jang IJ; Yu KS; Lee S
Drug Des Devel Ther; 2019; 13():3879-3885. PubMed ID: 32009778
[TBL] [Abstract][Full Text] [Related]
18. Comparative Pharmacokinetics Between a Fixed-Dose Combination of Pitavastatin/Valsartan 4/160 mg and the Corresponding Individual Components Through a Partial Replicated Crossover Design in Healthy Male Subjects.
Na JY; Yang E; Kim JH; Kwon IS; Jin EH; Yu KS; Kim J; Lee S; Hong JH
Clin Pharmacol Drug Dev; 2022 May; 11(5):615-622. PubMed ID: 34997835
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic and bioequivalence study of a fixed-dose combination of amlodipine besylate and rosuvastatin calcium compared to co-administration of separate tablets in healthy Korean subjects
.
Park JS; Jeon JY; Kim MG
Int J Clin Pharmacol Ther; 2019 Dec; 57(12):612-622. PubMed ID: 31549624
[TBL] [Abstract][Full Text] [Related]
20. Bioequivalence and Pharmacokinetics of Bisoprolol-Amlodipine 5 mg/5 mg Combination Tablet versus Bisoprolol 5 mg Tablet and Amlodipine 5 mg Tablet: An Open-Label, Randomized, Two-Sequence Crossover Study in Healthy Chinese Subjects.
Hu C; Hu X; Wang C; Zhao Z; Gao D; Chen X; Zhou D; Huang Y; Li L; Zhang L
Clin Drug Investig; 2018 Dec; 38(12):1145-1154. PubMed ID: 30232699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
